All About the Process
Content agility is the first step to digital transformation.
Collaboration & Community: The Transition to Open Access
Copyright Clearance Center hosted an expert panel discussion, “Collaboration & Community: The Transition to Open Access,” at The London Book Fair, assessing the state of OA today.
2 Real World Examples: Using Real World Data for Commercial Pharmaceutical Product Insights
Here is a look at two pharmaceutical use cases where text mining has transformed real world data into real world evidence.
Small Steps, Giant Leaps: The Digital Transformation Experience
At the 2018 London Book Fair, experts from Ixxus, Alfresco, SAGE London, Bloomsbury Publishing Plc and Whizz Education discussed the digital transformation journey.
Survey Says: Transition to Open Access Publishing Can’t Happen Fast Enough
Most respondents to the Springer Nature survey said the move to all future scholarly articles being made accessible via open access was only just a matter of time, with two-thirds hopeful it could happen within 10 years.
Should Commercial Teams be Involved Earlier in the Drug Development Cycle? Research Suggests Yes
Commercial teams can no longer afford to be operating separately from R&D – silos between the two operations will start to break down.
Tom Brady, Walt Disney and the Unexpected Copyright Cases of Early 2018
Over the past few weeks, The Walt Disney Company and Tom Brady, have each landed in the press over lawsuits involving copyright infringement.
Join CCC at the STM U.S. Conference 2018
Join CCC and Ixxus in Philadelphia for the STM U.S. Conference 2018 from April 24-26, where publishers and other stakeholders gather to collaboratively answer the question, “What can we do better, together?”
Is OER Sustainable? 3 Examples that Suggest “Yes”
The migration of publishers and techies to OER organizations is one sign that the lines between OER and publisher programs are starting to blur.
Drug Repurposing, Rare Diseases and Semantic Analytics
Drug repurposing could help find cures for rare diseases faster, but trawling through research is a time-consuming and resource-heavy task.